Eli Lilly & Co. (LLY)
1157.93
-16.68
(-1.42%)
USD |
NYSE |
Aug 31, 16:00
1161.07
+3.14
(+0.27%)
After-Hours: 20:00
Eli Lilly Net Income (TTM) : 26.71B for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.71B |
| March 31, 2026 | 25.28B |
| December 31, 2025 | 20.64B |
| September 30, 2025 | 18.41B |
| June 30, 2025 | 13.80B |
| March 31, 2025 | 11.11B |
| December 31, 2024 | 10.59B |
| September 30, 2024 | 8.370B |
| June 30, 2024 | 7.342B |
| March 31, 2024 | 6.138B |
| December 31, 2023 | 5.240B |
| September 30, 2023 | 4.988B |
| June 30, 2023 | 6.498B |
| March 31, 2023 | 5.687B |
| December 31, 2022 | 6.245B |
| September 30, 2022 | 6.033B |
| June 30, 2022 | 5.692B |
| March 31, 2022 | 6.129B |
| December 31, 2021 | 5.582B |
| September 30, 2021 | 5.972B |
| June 30, 2021 | 6.071B |
| March 31, 2021 | 6.092B |
| December 31, 2020 | 6.194B |
| September 30, 2020 | 5.573B |
| June 30, 2020 | 5.618B |
| Date | Value |
|---|---|
| March 31, 2020 | 5.533B |
| December 31, 2019 | 4.638B |
| September 30, 2019 | 4.264B |
| June 30, 2019 | 4.103B |
| March 31, 2019 | 2.544B |
| December 31, 2018 | 3.151B |
| September 30, 2018 | 372.30M |
| June 30, 2018 | -165.70M |
| March 31, 2018 | 1.074B |
| December 31, 2017 | -204.10M |
| September 30, 2017 | 2.225B |
| June 30, 2017 | 2.447B |
| March 31, 2017 | 2.187B |
| December 31, 2016 | 2.738B |
| September 30, 2016 | 2.444B |
| June 30, 2016 | 2.466B |
| March 31, 2016 | 2.319B |
| December 31, 2015 | 2.408B |
| September 30, 2015 | 2.358B |
| June 30, 2015 | 2.059B |
| March 31, 2015 | 2.192B |
| December 31, 2014 | 2.390B |
| September 30, 2014 | 2.690B |
| June 30, 2014 | 3.392B |
| March 31, 2014 | 3.865B |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Johnson & Johnson | 21.04B |
| Merck & Co., Inc. | 3.169B |
| Pfizer Inc. | 4.373B |
| Bristol Myers Squibb Co. | 9.275B |
| Atai Beckley, Inc. | -668.29M |